CEAg World Conference and Expo

Overview

The CEAg World Conference and Expo will empower growers by exploring and advancing Controlled Environment Agriculture (CEA) practices.

From sophisticated greenhouse systems to aquaponics for covering solutions like high tunnels and hoop houses, this conference will deliver tools, insights and connections to help produce businesses achieve year-round success.

Attend this event to:

Connect with industry experts and stakeholders dedicated solely to Advancing Food Under Cover
Experience the newest products and technologies driving success in CEA at the Expo Hall and Innovation Stage
Discover best practices and strategies to maximize growth, profitability, and sustainability in CEA
Conquer today's toughest challenges with immediate solutions to accelerate your path to success

Registration

November 19, 2025 9:00am - November 21, 2025 4:00pm

Durham, NC

Visit Registration Page for Pricing Information

Agtech

June 24, 2026

Concept to Commercialization: An Owner’s Perspective on the Modern Pharma Project Lifecycle

This event brings together life sciences leaders to discuss the realities of navigating today’s pharmaceutical projects, from early planning and design through startup, validation, and commercial readiness.

Panelists will discuss owner-side perspectives on project execution, operational readiness, collaboration, and the evolving challenges shaping modern life sciences facilities and manufacturing environments.

Featured Panelists:

September 17, 2026

UNC Women's Health Research Symposium

The inaugural Women's Health Multidisciplinary Research Symposium, to be held at UNC, will foster interdisciplinary connections, collaboration, and knowledge sharing among trainees and faculty passionate about women’s health research.

This symposium is hosted by the Women’s Health Multidisciplinary Consortium (WHMC) and the Department of Pathology and Laboratory Medicine and supported by the Center for Women’s Health Research and the School of Medicine’s Department of Obstetrics & Gynecology.

June 18, 2026

United Therapeutics receives FDA clearance for xenoheart clinical trial

United Therapeutics Corporation, a public benefit corporation with co-headquarters in Research Triangle Park, has received U.S. Food and Drug Administration (FDA) clearance under the company’s Investigational New Drug application to proceed with a clinical study of its investigational UHeart xenoheart derived from a pig.